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Objective: To compare costs of function- and pain-centred 
inpatient treatment in patients with chronic low back pain 
over 3 years of follow-up. 
Design: Cost analysis of a randomized controlled trial. 
Patients: A total of 174 patients with chronic low back pain 
were randomized to function- or pain-centred inpatient 
treatment. 
Methods: Data on direct and indirect costs were gathered by 
questionnaires sent to patients, health insurance providers, 
employers, and the Swiss Disability Insurance Company. 
Results: There was a non-significant difference in total medi-
cal costs after 3 years’ follow-up. Total costs were 77,305 
Euros in the function-centred inpatient treatment group 
and 83,085 Euros in the pain-centred inpatient treatment 
group. Likewise, indirect costs after 3 years from lost work 
days were non-significantly lower in the function-centred 
in patient treatment group (6354 Euros; 95% confidence in-
terval –20,892, 8392) and direct medical costs were non-sig-
nificantly higher in the function-centred inpatient treatment 
group (574 Euros; 95% confidence interval –862, 2011). 
Conclusion: The total costs of function-centred and pain-
centred inpatient treatment were similar over the whole 
3-year follow-up. 
Key words: low back pain, exercise therapy, vocational rehabili-
tation, rehabilitation outcome, costs, cost analysis.
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INTRODUCTION
In Switzerland musculoskeletal disorders represent the third 
largest illness group, resulting in 9.4 million consultations per 
year (1). Of these, approximately 30% are for low back pain 
(LBP). In 2002 LBP had the highest prevalence of all medical 
conditions in the working age population in Switzerland, with 
8% of women and 13% of men affected in a 4-week period (2). 
Total costs of LBP in Switzerland are estimated at 7.4 billion 
Euros, of which direct medical costs are 3.4 billion Euros (6.7% 
of total Swiss healthcare expenditure), and indirect costs to 4.0 
billion Euros (3). Furthermore, chronic LBP, defined as LBP 
present for more than 12 weeks, is one of the most frequent 
reasons for persistent disability and lost work days. The ex-
penses of the Swiss Disability Insurance Company increased by 
215% from 1990 to 2005, and approximately 20% of disability 
pensions in 2008 were due to musculoskeletal diseases, among 
which chronic LBP plays a predominant role (4). 
Similar figures are reported from other industrialized coun-
tries (5–8). In the USA chronic LBP causes 33–41% of all 
work-related pension costs and is responsible for 16–19% of 
disability pensions (9). The highly skewed distribution of costs 
due to LBP is well documented, with patients with chronic 
LBP accounting for up to 80% of total costs associated with 
LBP (10, 11). Meta-analyses have shown that exercises and 
multidisciplinary function-oriented rehabilitation programmes 
with the aims of changing illness behaviour and improving 
physical function can reduce pain and disability and increase 
the number of work days among patients with chronic LBP (12, 
13). Regarding long-term costs, these programmes have not 
yet been well evaluated, but cost data are of great importance 
for health authorities.
Despite consensus in the literature promoting function-
oriented treatment, pain- and symptom-oriented treatments for 
patients with chronic LBP are still widely used in Switzerland. 
Earlier, we performed a randomized controlled trial (RCT) in 
patients with chronic LBP and work-related disability, compar-
ing a function-centred inpatient treatment (FCT) programme 
with a pain-centred inpatient treatment (PCT) programme in 
Switzerland (14). After 12 months follow-up post-treatment, 
the FCT programme significantly increased the number of days 
at work compared with the PCT programme (15). 
The aim of the present study was to compare direct medical 
costs and indirect costs from productivity loss and disability 
pensions of this patient population after 1 and 3 years. Our a 
priori hypothesis was that the FCT programme would also be 
cost beneficial over the 3 years of follow-up.
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METHODS
Patient selection, randomization and data collection
Cost analyses of treatment outcomes were performed in a RCT with 3 
years’ follow-up. The study was registered at ClinicalTrials.gov (ID: 
NCT 00652236) and approved by the ethics committee of the Canton 
St Gallen, Switzerland (EKSG 03/035). Between January 2000 and 
May 2003 we recruited patients attending a rehabilitation centre for 
work-related health problems in Valens, Switzerland. Eligible patients 
were between 20 and 55 years with chronic non-specific LBP accord-
ing the Quebec Task Force classification (16) who had taken at least 
6 weeks of sick leave due to LBP in the previous 6 months. Patients 
with co-morbidities interfering with treatment or ability to work, and 
patients with two or more positive predictive tests for non-return-to-
work according to Kool et al. (17) were excluded. 
Patients who gave informed consent to participate were divided into 
4 strata, defined by work status (employed, unemployed) and work-load 
(lifting loads < 10 kg or > 10 kg) based on the definitions of the US 
Department of Labour (18). An independent blinded research assist-
ant performed concealed randomization within strata. Two separate 
teams of therapists treated patients 6 days per week for a 3-week 
period in the FCT and PCT programmes. Patients in one programme 
were not informed about the treatment of the other programme. To 
ensure that patients were unaware of the other treatment they stayed 
in different wards in order to reduce contact with patients from the 
other treatment group. 
An independent blinded research assistant assessed costs and number 
of work days after 1 and 3 years of follow-up based on questionnaires 
sent to patients, employers, health insurance providers, and the Swiss 
Disability Insurance Company. Respondents were blinded to treatment 
assignment and non-respondents received up to 2 reminders within 2 
months of the original request.
Treatment 
Function-centred treatment. FCT was based on a functional restoration 
programme for 4 h per day for 3 weeks. The programme comprised 
work simulation, strength and endurance training through isokinetic 
exercise, cardiovascular training, sports therapy, and independent 
exercise. FCT used only group treatment offered by 2 therapists for 
groups of 8 patients. Therapist time per patient was approximately 
1 h per day. 
Pain-centred treatment. The PCT programme was 2.5 h per day includ-
ing 1 h of individual treatment and 1 and 0.5 h of treatment in groups 
of 8 patients. The PCT programme included mobilization, stretching, 
strength training, aquatic exercises and a mini-back-school. Passive 
pain modulating treatments (hot packs, electrotherapy, and massage) 
were also used. Estimated therapist time per patient was approximately 
1.25 h per day. The treatment duration was 3 weeks. 
In both groups, a rheumatologist prescribed medications and applied 
local injections in the musculature and other soft tissue of the lumbar 
region when deemed medically necessary. If required, a psychologist 
also offered counselling. Treatment following rehabilitation was at 
the discretion of the patient’s primary physician, but patients in the 
PCT programme were told to continue with their independent exer-
cises twice weekly if they were pain-free, while patients in the FCT 
programme were encouraged to continue their strength and endurance 
training twice weekly even if they had pain. 
Outcome measurement 
Costs were considered from a societal perspective (direct medical 
costs and productivity losses), a health insurance perspective (direct 
medical costs) and a disability pension fund perspective (disability 
pension payments). 
Initial funding included 1 year follow-up. Additional funding was 
obtained for 3 year follow-up and assessed costs during the second and 
third year. All cost data were recorded in Swiss Francs and converted 
to Euros (exchange rate 1 January 2007: 1.604 CHF/1 Euro).
Direct costs. Direct costs of inpatient treatments were calculated 
based on daily rates. Cost per unit accounting was not used in the 
study centre, thus detailed per patient costs of personnel, material 
and overhead were not available. Data on direct medical costs during 
the 3 year follow-up period were collected by questionnaire sent to 
patients’ health insurance providers. We requested data on the total 
amount of costs related to the treatment of LBP. Unfortunately, health 
insurance providers were not able to report specifically on LBP-related 
healthcare consumption, although Swiss physicians are obliged to 
indicate the reasons and diagnoses for all healthcare reimbursement 
claims. Therefore, reported direct cost data are not LBP-specific, but 
represent the total costs of healthcare consumption. Direct cost data 
represent the lower bound of total direct medical costs because they 
do not include cost sharing and out-of-pocket payments by patients 
and public subsidies to hospitals. 
Indirect costs. Indirect costs were assessed by questionnaire sent to 
patients and employers. As work absenteeism is the main cost factor 
regarding indirect costs, and no national database is available to as-
sess work days, these data were assessed with questionnaires. Patient 
questionnaires were used to assess working status (currently working 
or not) and disability insurance status (whether the patient received 
a disability pension). The employer questionnaire assessed work 
absenteeism and disability-related reductions in daily working hours. 
In case of disagreement patients and employers were contacted by 
telephone to resolve the differences. Time-reduced work was taken 
into account. For example, a work day with 30% time reduction was 
counted as 0.7 work days. The costs for days on sick leave were then 
calculated according to a human capital approach by multiplying time 
on sick leave with the patients’ pre-tax income as a proxy for the value 
of lost productivity. 
Detailed information on disability pensions was obtained from 
the Swiss Disability Insurance Company and included the date of 
adjudication of the disability pension, monthly payment amount, and 
the degree of the disability pension (i.e. 25%, 50%, 75%, or 100% 
according to their disability level). Partial disability pensions were 
analysed in the same manner as time-reduced work. Total transfers 
for disability payments were calculated by multiplying the number of 
months with a disability pension in the 3-year period with the monthly 
pension. The analysis of disability pensions was complicated by the 
long time period between the application and the decision by the Swiss 
Disability Pension Company. At the end of 2007 the applications of 12 
patients were still unsettled. Furthermore, 10 patients withdrew their 
informed consent during the follow-up period and 18 patients could 
not be contacted because they moved back in their home countries and 
no forwarding addresses were provided.
For further analyses costs arising form work absenteeism and 
productivity losses and disability pension costs were summarized 
under the term “indirect costs”, although in modern health economics 
disability pensions are not part of indirect costs as they are income 
transfers and not productivity losses.
Statistics 
Power calculations based on the primary outcome, work days during 
the first year after treatment, using a type I error of 0.05 and 80% 
power, indicated that 90 patients per group were needed to detect a 
difference of 40 work days between the 2 treatment groups during 
the first follow-up year. Because the RCT recruitment rate was lower 
than expected, only 174 patients instead of the planned 180 patient 
were included. Intention-to-treat analyses were conducted using Stata 
statistical software (Stata Corporation, College Station, TX, USA), 
version 9.
Tests for differences between the 2 treatment groups were performed 
with the 2-sample t-tests (Student’s t-test). Although the distribution of 
the cost-data variables is often skewed, only the arithmetic mean is of 
relevance for cost analysis (19). Boot-strapping was used to determine 
confidence intervals (CI). 
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Cost analyses were performed after 1 and 3 years of follow-up. 
While the relevant data for cost analysis were complete for the first 
year, a number of patients withdrew their informed consent, or data 
were missing for other reasons, in the subsequent years. Missing data 
for the number of work days between 1 and 3 years’ follow-up were 
imputed with a least-squares regression and a logistic hurdle model. 
These methods do not affect the magnitude of the differences between 
the treatment groups, but improve the precision of the estimates. 
Logistic hurdle regression is particularly useful for count data with 
an excess of zero counts. In a first step, logistic regression was used 
for analysing patients without work days or disability pension. In the 
second step, a least-squares regression was used to impute the number 
of work days or the disability allowance. 
RESULTS
Participants
Fig. 1 shows the study flow of the patients. Cost analysis of 
the 3-year follow-up period was reduced to 171 patients, as 2 
patients died after the first year and one patient was excluded 
due to an exceedingly high number of missing values. Baseline 
characteristics of the patients in the 2 groups are listed in Table I. 
Missing data were imputed for numbers of work days in 38 
patients (FCT n = 14, PCT n = 24) and disability pension in 29 
patients (FCT n = 11, PCT n = 18). After 3 years, 131 patients 
received a disability pension and were included in the exami-
nation of the effects of the treatments on disability pensions 
over the whole follow-up period.
Costs
The results of cost calculations in the 2 follow-up periods are 
shown in Table II. 
There was a non-statistically significant difference in total 
costs of the 2 treatment groups. Total costs were higher in the 
PCT group, with a difference of 3132 Euros (95% CI –7307 to 
1044; p = 0.08) after 1 year, and to 5780 Euros (95% CI –18,363 
to 6477; p = 0.18) after 3 years. Costs of inpatient treatment 
were the same in both groups (FCT 5889 Euros, PCT 5935 
Euros). Direct medical costs after 1 year were significantly 
higher in the FCT group (732, 95% CI 33–1431; p = 0.02). No 
other differences in direct and indirect costs were found during 
the 3 year follow-up period. 
Fig. 1. Patients in the study (according to the CONSORT statement).
Table I. Baseline characteristics of the patients in the function- or pain-
centred treatment (FCT or PCT) groups for chronic low back pain
Characteristics FCT PCT
Patients, n 87 84
Age, years, mean (SD) 41 (8) 43 (8)
Gender, men, % 79 78
Cultural background, n (%)
Switzerland 36 (43) 35 (42)
Southeast Europe* 18 (21) 13 (15)
Southwest Europe† 30 (36) 36 (43)
No professional education, n (%) 32 (38) 36 (43)
Heavy work (work load > 10 kg), n (%) 64 (76) 70 (83)
Days of sick leave in 2 years before 
treatment, mean (SD) 186 (161) 218 (154)
*Bosnia, Macedonia, Serbia, Turkey. 
†Italy, Portugal, Spain.
SD: standard deviation.
Table II. Direct, indirect and total costs in Euros* of the initial rehabilitation treatment (n = 174) and after 1 (n = 174) and 3 years (n = 171) in the 
two treatment groups
FCT PCT Difference FCT-PCT
p-value‡Mean SE Mean SE Mean 95% CI†
Rehabilitation treatment
Direct costs 5,889 106 5,935 107 –46 –342–252 0.77
1 year
Direct costs 2,658 282 1,926 226 732 33–1,431 0.02
Indirect costs 22,737 1,627 26,601 1,341 –3,864 –8,132–405 0.10
Total costs 25,395 1,714 28,527 1,379 –3,132 –7,307–1,044 0.08
3 years
Direct costs 4,843 561 4,269 496 574 –862–2,011 0.22
Indirect costs 72,462 4,619 78,816 4,072 –6,354 –20,892–8,392 0.15
Total costs 77,305 4,747 83,085 4,231 –5,780 –18,363–6,477 0.18
*Original values in Swiss Francs. Exchange rate 1 January 2007: 1.604 CHF/1 Euro.
†Estimated by boot-strapping.
‡Independent 2-sample t-test.
CI: confidence interval; FCT: function-centred treatment; PCT: pain-centred treatment; SE: standard error.
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DISCUSSION
To our knowledge this is the first study in Switzerland compar-
ing the costs of function-centred and pain-centred inpatient 
rehabilitation programmes with 3 years follow-up. With regard 
to all costs we could not show a statistically significant dif-
ference between the 2 rehabilitation programmes over the 3 
years of follow-up. Therefore, our a priori hypothesis, that the 
FCT programme would be cost beneficial over the 3-years of 
follow-up, has to be rejected. 
Nevertheless, we found a small (but non-statistically signifi-
cant) cost benefit from the FCT programme. The difference in 
total costs over 3 years amounted to 5780 Euros in favour of 
the FCT, corresponding to approximately 2 months’ salary for 
an average Swiss blue-collar employee. Direct medical costs 
were higher in the FCT programme in the first year, but this 
was offset by lower indirect costs over the 3-year follow-up 
period. 
Some differences between our results and other research 
evaluating costs from LBP need to be taken into considera-
tion. In an earlier observational study of a FCT programme 
we collected and calculated all programme costs over a 1-year 
period (20); direct medical costs were 7802 Euros per patient 
and indirect costs 26,000 Euros per patient. Compared with 
the present study, direct costs of our observational study were 
higher at 1-year follow-up, while the indirect costs are com-
parable. This difference may be due to the different methods 
used to determine direct medical costs, while the indirect 
costs were calculated similarly in both studies. Specifically, 
in our earlier study, direct costs were assessed using data 
from primary care physicians (e.g. number of visits, number 
of medications, and number of radiographs during the 1-year 
follow-up) and then valued, whereas in the present study cost 
data from the health insurance providers was used. Therefore, 
it could be that, in the present trial, not all consultations or all 
medications were reported to the health insurance provider, 
or that some were paid by the patients, leading to lower direct 
costs. Compared with the cross-sectional survey by Ekman et 
al. (21) of patients with chronic LBP in a primary care setting 
in Sweden, the direct medical costs in our RCT were slightly 
lower (2300 vs 3100 Euros) and indirect costs slightly higher 
(24,600 vs 17,600 Euros). These discrepancies might be due 
to the differences in recruitment, inclusion criteria, rates and 
salaries. Ekman et al. (21) included patients with chronic LBP 
in a primary care setting, whereas we studied patients who 
participated in an inpatient rehabilitation programme. In the 
primary care setting, the duration of the complaints is shorter 
and the probability of patients returning to work is therefore 
higher, leading to lower indirect costs. Patients participating 
in an inpatient rehabilitation programme are examined and 
documented thoroughly so that no further expensive investi-
gations are necessary after discharge, and subsequent direct 
costs are expected to be lower. Steenstra et al. (22) published 
an economic evaluation of a multi-stage return-to-work pro-
gramme for workers on sick leave due to LBP. Similar to our 
FCT programme, the return-to-work programme resulted in a 
statistically significant increase in work days after 52 weeks 
at slightly higher treatment costs compared with usual care. 
From a societal perspective, the higher direct medical costs of 
work-related interventions over the first year were offset by 
lower indirect costs from sick leave and disability pensions 
during the first year of follow-up.
Several limitations and strengths should be mentioned. Insuf-
ficient power is a limitation of this study that probably con-
tributes to the imprecision of between-group cost differences. 
The a priori power calculation was based on the number of 
work days during the first follow-up year; therefore, this study 
was underpowered for cost analyses over 3 years of follow-up. 
Insufficient power is a common problem in cost-effectiveness 
studies, which are often performed alongside RCTs (23). An-
other limitation of our study is the low treatment contrast, as 
both groups received 3 weeks of inpatient rehabilitation. Be-
cause we recruited patients from a single rehabilitation centre 
with an established care protocol it would have been unethical 
and medically impossible to use a “usual care” or “no treat-
ment” control group. An earlier meta-analysis demonstrated 
larger effects in experimental studies comparing exercise with 
usual care than in studies comparing 2 treatments that both 
used exercise (13). Therefore, the effect on costs of FCT, if 
compared with “usual care”, is expected to be larger. 
In this pragmatic trial the intensity of treatment (treatment 
hours per day) was different. The number of treatment hours 
was higher in the FCT group. This is due to the fact that FCT 
was based on the concept of work-hardening programmes 
using behavioural principles and exercise aiming at facilitat-
ing return to work and increasing activity despite pain. The 
PCT group passed a more traditional “usual care” programme 
with a biomedical approach to reduce pain as a primary goal 
before increasing activity. Furthermore, patients in the FCT 
were told to continue their training despite pain. All these facts 
may have influenced the outcomes in favour of the small, but 
non-significant, effects of the FCT, since recent trials reported 
better outcomes in patients with chronic LBP using a work-
hardening approach (13) or an intensive training programme 
(12). Although we made all attempts to minimize confounding 
by keeping patients unaware of the other treatment, it cannot be 
ruled out that discussions between patients regarding therapy 
components and goals affected the results. Another limitation 
of our study is that health insurance providers reported total 
costs without distinguishing between costs attributable to LBP 
and other diseases. This may have resulted in an overestima-
tion of LBP-associated direct medical costs in both groups, 
but would not be a systematic bias affecting the main results 
or conclusions, because between-group comparisons were 
performed. Additionally, direct costs data from health insur-
ance providers are considered to be more accurate than infor-
mation from patients, physicians or healthcare professionals. 
In Switzerland, patients are free to visit specialists and other 
healthcare professionals without contacting their primary care 
physician, thus tracing all healthcare professionals involved 
in care is difficult. 
Finally, there was a non-statistically significant difference at 
baseline in days of sick leave in the 2 years before treatment. 
In the analysis and presentation of the work days results (15) 
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we took into account potential pre-treatment covariates as sick 
leave before treatment, age, sex, education, job qualification 
and cultural background. Including these covariates in the 
analysis did not change the results. Therefore we believe that 
the differences in the current results after the first year can be 
attributed to the effect of FCT and not to baseline differences 
between groups.
Taking into account the 3-year follow-up duration, a major 
strength of this study is the relatively high completeness of 
data (75%). Another strength is that this study is based on ac-
tual and reliable data from health insurance providers and the 
Swiss Disability Insurance Company. In contrast, other cost-
effectiveness analyses often use modelling techniques based 
on best estimates of expected costs and benefits. Data from the 
Swiss Disability Insurance Company are the best available in 
Switzerland, as every person that is out of work due to an illness 
or injury is reported to this insurance for the purpose of voca-
tional measures or pension payments. However, our reported 
data may underestimate total indirect costs because they do not 
consider lower productivity in the workplace (presenteeism) 
and possible replacement costs for the employer. 
In conclusion, this cost analysis of a RCT with 3-year follow-
up showed similar costs of function- and pain-centred treatment 
programmes. The cost benefit for the FCT programme, of 5780 
Euros, was not significant. Because costs are similar, and the 
current literature promotes active function-oriented therapies 
in the treatment of patients with chronic LBP, we believe 
that FCT programmes should be the treatment of choice for 
patients with chronic non-specific LBP. Nevertheless, further 
cost analyses in larger studies are urgently needed.
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